866-997-4948(US-Canada Toll Free)

Periodontal Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : May 2018

Category :

Pharmaceutical

No. of Pages : 179 Pages

Periodontal Therapeutics Market – Overview

Periodontal therapeutics are effective adjunctive therapies used in the treatment of periodontal pathogens. These therapies include systemic antibiotics, such as doxycycline, minocycline, metronidazole, and other antibiotics comprising amoxicillin, azithromycin, etc. and local antibiotics, including Arestin, Atridox, PerioChip, and others. This report analyzes the current and future prospects of the periodontal therapeutics market based on product type, distribution channel, and geography.

This study is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the periodontal therapeutics market in the near future. Primary research formed the bulk of our research efforts, with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation, and various international and national databases. The report provides estimated market size in terms of US$ Mn (US$ in million) for product type, distribution channel, and geography for the period of 2018 to 2026.

The report contains an elaborative executive summary, which includes market snapshot providing information on various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product type, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that can influence the periodontal therapeutics market in the current and future scenario. The report also provides Porter’s five force analysis that studies five factors and their impact on the periodontal therapeutics market.

Market share of key players is analyzed to signify the contribution of these players toward the revenue of the market. As such, these factors are likely to help market players in deciding about business strategies and plans for strengthening their position in the global market. Based on geography, the market has been analyzed for five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis in these regions for the periodontal therapeutics market.

The report also profiles major players in the periodontal therapeutics market and provides their key attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, and Kaken Pharmaceutical Co., Ltd. Inorganic growth measurements and business collaborations were the primary strategies adopted by the major market players to cement their position in the periodontal therapeutics market.

The periodontal therapeutics market has been segmented as follows:

  • Periodontal Therapeutics Market, by Product Type, Revenue (US$ Mn) 2018-2026
    • Systemic Antibiotics
      • Doxycycline
      • Minocycline
      • Metronidazole
      • Others
    • Local Antibiotics
      • Arestin
      • Atridox
      • PerioChip
      • Others
  • Periodontal Therapeutics Market, by Distribution Channel, Revenue (US$ Mn) 2018-2026
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • E-commerce
  • Periodontal Therapeutics Market, by Geography, Revenue (US$ Mn), 2018-2026
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • GCC Countries
      • Israel
      • Rest of Middle East & Africa

Table of Content

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Periodontal Therapeutics Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution/Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Periodontal Therapeutics Market Analysis and Forecast, 2016–2026
     4.5. Porter’s Five Force Analysis

5. Market Outlook

6. Global Periodontal Therapeutics Market Analysis and Forecast, by Product
     6.1. Introduction & Definition
     6.2. Key Findings/Developments
     6.3. Market Value Forecast, by Product, 2016–2026
            6.3.1. Systemic Antibiotics
                     6.3.1.1. Doxycycline
                     6.3.1.2. Minocycline
                     6.3.1.3. Metronidazole
                     6.3.1.4. Others
            6.3.2. Local Antibiotics
                     6.3.2.1. Arestin
                     6.3.2.2. Atridox
                     6.3.2.3. PerioChip
                     6.3.2.4. Others
     6.4. Market Attractiveness, by Product

7. Global Periodontal Therapeutics Market Analysis and Forecast, by Distribution Channel
     7.1. Introduction & Definition
     7.2. Key Findings/Developments
     7.3. Market Value Forecast, by Distribution Channel, 2016–2026
            7.3.1. Hospitals Pharmacies
            7.3.2. Retail Pharmacies
            7.3.3. Drug Stores
            7.3.4. E-commerce
     7.4. Market Attractiveness, by Distribution Channel

8. Global Periodontal Therapeutics Market Analysis and Forecast, by Region
     8.1. Key Findings
     8.2. Market Value Forecast, by Region
            8.2.1. North America
            8.2.2. Europe
            8.2.3. Asia Pacific
            8.2.4. Latin America
            8.2.5. Middle East & Africa
     8.3. Market Attractiveness, by Country/Region/Sub-region

9. North America Periodontal Therapeutics Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Market Value Forecast, by Product, 2016–2026
            9.2.1. Systemic Antibiotics
                     9.2.1.1. Doxycycline
                     9.2.1.2. Minocycline
                     9.2.1.3. Metronidazole
                     9.2.1.4. Others
            9.2.2. Local Antibiotics
                     9.2.2.1. Arestin
                     9.2.2.2. Atridox
                     9.2.2.3. PerioChip
                     9.2.2.4. Others
     9.3. Market Value Forecast, by Distribution Channel, 2016–2026
            9.3.1. Hospitals Pharmacies
            9.3.2. Retail Pharmacies
            9.3.3. Drug Stores
            9.3.4. E-commerce
     9.4. Market Value Forecast, by Country, 2016–2026
            9.4.1. U.S.
            9.4.2. Canada
     9.5. Market Attractiveness Analysis
            9.5.1. by Product
            9.5.2. by Distribution Channel
            9.5.3. by Country

10. Europe Periodontal Therapeutics Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product, 2016–2026
            10.2.1. Systemic Antibiotics
                     10.2.1.1. Doxycycline
                     10.2.1.2. Minocycline
                     10.2.1.3. Metronidazole
                     10.2.1.4. Others
            10.2.2. Local Antibiotics
                     10.2.2.1. Arestin
                     10.2.2.2. Atridox
                     10.2.2.3. PerioChip
                     10.2.2.4. Others
     10.3. Market Value Forecast, by Distribution Channel, 2016–2026
            10.3.1. Hospitals Pharmacies
            10.3.2. Retail Pharmacies
            10.3.3. Drug Stores
            10.3.4. E-commerce
     10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
            10.4.1. Germany
            10.4.2. U.K.
            10.4.3. France
            10.4.4. Italy
            10.4.5. Spain
            10.4.6. Rest of Europe
     10.5. Market Attractiveness Analysis
            10.5.1. by Product
            10.5.2. by Distribution Channel
            10.5.3. by Country

11. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast
     11.1.Introduction
            11.1.1. Key Findings
     11.2.Market Value Forecast, by Product, 2016–2026
            11.2.1. Systemic Antibiotics
                     11.2.1.1. Doxycycline
                     11.2.1.2. Minocycline
                     11.2.1.3. Metronidazole
                     11.2.1.4. Others
            11.2.2. Local Antibiotics
                     11.2.2.1. Arestin
                     11.2.2.2. Atridox
                     11.2.2.3. PerioChip
                     11.2.2.4. Others
     11.3.Market Value Forecast, by Distribution Channel, 2016–2026
            11.3.1. Hospitals Pharmacies
            11.3.2. Retail Pharmacies
            11.3.3. Drug Stores
            11.3.4. E-commerce
     11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
            11.4.1. Japan
            11.4.2. China
            11.4.3. India
            11.4.4. Australia & New Zealand
            11.4.5. Rest of Asia Pacific
     11.5.Market Attractiveness Analysis
            11.5.1. by Product
            11.5.2. by Distribution Channel
            11.5.3. by Country

12. Latin America Periodontal Therapeutics Market Analysis and Forecast
     12.1.Introduction
            12.1.1. Key Findings
     12.2.Market Value Forecast, by Product, 2016–2026
            12.2.1. Systemic Antibiotics
                     12.2.1.1. Doxycycline
                     12.2.1.2. Minocycline
                     12.2.1.3. Metronidazole
                     12.2.1.4. Others
            12.2.2. Local Antibiotics
                     12.2.2.1. Arestin
                     12.2.2.2. Atridox
                     12.2.2.3. PerioChip
                     12.2.2.4. Others
     12.3.Market Value Forecast, by Distribution Channel, 2016–2026
            12.3.1. Hospitals Pharmacies
            12.3.2. Retail Pharmacies
            12.3.3. Drug Stores
            12.3.4. E-commerce
     12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Rest of Latin America
     12.5.Market Attractiveness Analysis
            12.5.1. by Product
            12.5.2. by Distribution Channel
            12.5.3. by Country

13. Middle East & Africa Periodontal Therapeutics Market Analysis and Forecast
     13.1.Introduction
            13.1.1. Key Findings
     13.2.Market Value Forecast, by Product, 2016–2026
            13.2.1. Systemic Antibiotics
                     13.2.1.1. Doxycycline
                     13.2.1.2. Minocycline
                     13.2.1.3. Metronidazole
                     13.2.1.4. Others
            13.2.2. Local Antibiotics
                     13.2.2.1. Arestin
                     13.2.2.2. Atridox
                     13.2.2.3. PerioChip
                     13.2.2.4. Others
     13.3.Market Value Forecast, by Distribution Channel, 2016–2026
            13.3.1. Hospitals Pharmacies
            13.3.2. Retail Pharmacies
            13.3.3. Drug Stores
            13.3.4. E-commerce
     13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
            13.4.1. GCC Countries
            13.4.2. South Africa
            13.4.3. Israel
            13.4.4. Rest of Middle East & Africa
     13.5.Market Attractiveness Analysis
            13.5.1. by Product
            13.5.2. by Distribution Channel
            13.5.3. by Country

14. Competition Landscape
     14.1.Market Player – Competition Matrix (By Tier and Size of companies)
     14.2.Market Share Analysis, by Company (2017)
     14.3. Competitive Business Strategies
     14.4. Company Profiles
            14.4.1. 3M Company
                     14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.4.1.2. Business Overview
                     14.4.1.3. Product Portfolio
                     14.4.1.4. Financial Overview
                     14.4.1.5. SWOT Analysis
                     14.4.1.6. Strategic Overview
            14.4.2. Den-Mat Holdings, LLC
                     14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.4.2.2. Business Overview
                     14.4.2.3. Product Portfolio
                     14.4.2.4. Financial Overview
                     14.4.2.5. SWOT Analysis
                     14.4.2.6. Strategic Overview
            14.4.3. Dexcel Pharma
                     14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.4.3.2. Business Overview
                     14.4.3.3. Product Portfolio
                     14.4.3.4. Financial Overview
                     14.4.3.5. SWOT Analysis
                     14.4.3.6. Strategic Overview
            14.4.4. Kaken Pharmaceutical Co., Ltd.
                     14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.4.4.2. Business Overview
                     14.4.4.3. Product Portfolio
                     14.4.4.4. Financial Overview
                     14.4.4.5. SWOT Analysis
                     14.4.4.6. Strategic Overview
            14.4.5. Oral Science
                     14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.4.5.2. Business Overview
                     14.4.5.3. Product Portfolio
                     14.4.5.4. Financial Overview
                     14.4.5.5. SWOT Analysis
                     14.4.5.6. Strategic Overview
            14.4.6. Valeant Pharmaceuticals International, Inc.
                     14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.4.6.2. Business Overview
                     14.4.6.3. Product Portfolio
                     14.4.6.4. Financial Overview
                     14.4.6.5. SWOT Analysis
                     14.4.6.6. Strategic Overview

List of Table

Table 01: Price Competitiveness between Atridox and Arestin
Table 02: Global Pipeline Analysis – Periodontal Therapeutics Drugs Market
Table 03: Global Periodontal Therapeutics Pipeline Drugs Market Size (US$ Mn) Forecast, 2019–2026
Table 04: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 05: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 06: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 07: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 08: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 12: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 13: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 14: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 15: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 16: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 17: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 18: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 19: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 20: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 21: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 22: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 23: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 24: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 25: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 26: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 27: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 28: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 29: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 30: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 31: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 32: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 33: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026

List of Chart

Figure 01: Global Market Revenue, by Product Type (US$ Mn), 2017
Figure 02: Global Market Revenue (US$ Mn), 2017
Figure 03: Global Periodontal Therapeutics Market Share Analysis
Figure 04: Porter’s Analysis
Figure 05: Pipeline Drugs Market Forecast, Research Methodology
Figure 06: Global PerioSept Market Revenue (US$ Mn), 2023–2026
Figure 07: Global Periodontal Therapeutics Market, by Product Type
Figure 08: Global Periodontal Therapeutics Market, by Product Type
Figure 09: Global Periodontal Therapeutics Market Value Share Analysis, by Product Type, 2016 and 2026
Figure 10: Global Periodontal Therapeutics Market Value Share Analysis, by Product Type, 2016 and 2026
Figure 11: Global Periodontal Therapeutics Market, by Product Type
Figure 12: Global Periodontal Therapeutics Market Value Share Analysis, by Product Type, 2016 and 2026
Figure 13: Global Systemic Antibiotics Market Revenue (US$ Mn) 2016–2026
Figure 14: Global Local Antibiotics Market Revenue (US$ Mn) 2016–2026
Figure 15: Global Periodontal Therapeutics Market Attractiveness Analysis, by Product Type, 2017
Figure 16: Global Doxycycline Market Revenue (US$ Mn) 2016–2026
Figure 17: Global Minocycline Market Revenue (US$ Mn) 2016–2026
Figure 18: Global Metronidazole Market Revenue (US$ Mn) 2016–2026
Figure 19: Global Others Market Revenue (US$ Mn) 2016–2026
Figure 20: Global Periodontal Therapeutics Market Attractiveness Analysis, by Systemic Antibiotics
Figure 21: Global Arestin Market Revenue (US$ Mn) 2016–2026
Figure 22: Global PerioChip Market Revenue (US$ Mn) 2016–2026
Figure 23: Global Atridox Market Revenue (US$ Mn) 2016–2026
Figure 24: Global Others Market Revenue (US$ Mn) 2016–2026
Figure 25: Global Periodontal Therapeutics Market Attractiveness Analysis, by Local Antibiotics, 2017
Figure 26: Global Periodontal Therapeutics Market Value Share Analysis, by Distribution 
Figure 27: Global Hospital Pharmacies Market Revenue (US$ Mn) 2016–2026
Figure 28: Global Retail Pharmacies Market Revenue (US$ Mn) 2016–2026
Figure 29: Global Drug Stores Market Revenue (US$ Mn) 2016–2026
Figure 30: Global E-commerce Market Revenue (US$ Mn) 2016–2026
Figure 31: Global Periodontal Therapeutics Market Attractiveness Analysis, by Distribution Channel
Figure 32: Global Periodontal Therapeutics Market Value Share Analysis, by Region, 2017 and 2026
Figure 33: Periodontal Therapeutics Market Attractiveness Analysis, by Region, 2017
Figure 34: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2016–2026
Figure 35: North America Market Attractiveness Analysis, by Country, 2017
Figure 36: North America Market Value Share Analysis, by Country, 2017 and 2026
Figure 37: North America Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 38: North America Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 39: North America Market Attractiveness Analysis, by Product Type, 2017
Figure 40: North America Market Attractiveness Analysis, by Distribution Channel Type, 2017
Figure 41: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2016–2026
Figure 42: Europe Market Attractiveness Analysis, by Country, 2017
Figure 43: Europe Market Value Share Analysis, by Country, 2017 and 2026
Figure 44: Europe Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 45: Europe Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 46: Europe Market Attractiveness Analysis, by Product Type, 2017
Figure 47: Europe Market Attractiveness Analysis, by Distribution Channel Type, 2017
Figure 48: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2016–2026
Figure 49: Asia Pacific Market Attractiveness Analysis, by Country, 2017
Figure 50: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2026
Figure 51: Asia Pacific Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 52: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 53: Asia Pacific Market Attractiveness Analysis, by Product Type, 2017
Figure 54: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2017
Figure 55: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2016–2026
Figure 56: Latin America Market Attractiveness Analysis, by Country, 2017
Figure 57: Latin America Market Value Share Analysis, by Country, 2017 and 2026
Figure 58: Latin America Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 59: Latin America Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 60: Latin America Market Attractiveness Analysis, by Product Type, 2017
Figure 61: Latin America Market Attractiveness Analysis, by Distribution Channel, 2017
Figure 62: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2016–2026
Figure 63: Middle East & Africa Market Attractiveness Analysis, by Country, 2017
Figure 64: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2026
Figure 65: Middle East & Africa Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 66: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 67: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2017
Figure 68: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2017
Figure 69: Global Periodontal Therapeutics Market Share Analysis, by Company (2017)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *